Article ; Online: Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2.
2020 Volume 144, Page(s) 110054
MeSH term(s) | Anti-Bacterial Agents/therapeutic use ; COVID-19/drug therapy ; Doxycycline/therapeutic use ; Humans ; Inflammation ; Minocycline/therapeutic use ; Models, Theoretical ; RNA, Double-Stranded/metabolism ; RNA, Ribosomal, 16S/metabolism ; RNA, Viral/metabolism ; Signal Transduction |
---|---|
Chemical Substances | Anti-Bacterial Agents ; RNA, Double-Stranded ; RNA, Ribosomal, 16S ; RNA, Viral ; Minocycline (FYY3R43WGO) ; Doxycycline (N12000U13O) |
Keywords | covid19 |
Language | English |
Publishing date | 2020-06-27 |
Publishing country | United States |
Document type | Letter |
ZDB-ID | 193145-3 |
ISSN | 1532-2777 ; 0306-9877 |
ISSN (online) | 1532-2777 |
ISSN | 0306-9877 |
DOI | 10.1016/j.mehy.2020.110054 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1132: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.